Related Experiment Video
Updated: May 18, 2026
11:36
A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
Glucocorticoids decrease body weight and food intake and inhibit appetite regulatory peptide expression in the
Xiao-Yan Liu1, Jian-Hua Shi, Wen-Hua DU
1Department of Endocrinology, No. 3 People's Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 201900;
Experimental and Therapeutic Medicine
|September 15, 2012
Summary
Glucocorticoids (GCs) reduced appetite and body weight in rats by decreasing hypothalamic neuropeptide Y (NPY), agouti-related protein (AGRP), and cocaine and amphetamine-regulated transcript (CART) mRNA expression.
Area of Science:
- Endocrinology
- Neuroscience
- Molecular Biology
Background:
- Glucocorticoids (GCs) are crucial hormones involved in stress response and metabolism.
- Appetite regulation is a complex process influenced by various neuropeptides in the hypothalamus.
- Dysregulation of appetite and metabolism is linked to obesity and metabolic disorders.
Purpose of the Study:
- To investigate the impact of GCs on appetite and the gene expression of key hypothalamic appetite regulatory peptides.
- To compare these effects in both non-obese and obese rat models.
- To explore the potential link between GC treatment, appetite, and metabolic disturbances.
Main Methods:
- Rats (non-obese and obese) were administered normal saline, low-dose, or high-dose GCs (hydrocortisone sodium succinate) via intraperitoneal injection for 20 days.
- Body weight and food intake were monitored throughout the study.
- Real-time quantitative PCR was used to measure the mRNA expression levels of neuropeptide Y (NPY), agouti-related protein (AGRP), and cocaine and amphetamine-regulated transcript (CART) in the hypothalamus.
Main Results:
- GC administration led to significant weight loss in both non-obese and obese rats, with higher doses causing greater weight reduction.
- Food intake was significantly reduced in rats treated with high-dose GCs compared to controls.
- mRNA expression of appetite-stimulating NPY and AGRP, and appetite-suppressing CART, were significantly downregulated in the hypothalamus of high-dose GC-treated rats.
Conclusions:
- Glucocorticoid treatment effectively decreases appetite and body weight in rats.
- GCs appear to exert these effects by downregulating the hypothalamic expression of appetite-regulating neuropeptides (NPY, AGRP, CART).
- Further research is needed to elucidate the precise mechanisms underlying GC-induced changes in neuropeptide expression and associated metabolic disturbances.
Related Concept Videos
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...